Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sofosbuvir 400 mg Tablets (Sovaldi vs HEPASOF) in Healthy Thai Volunteers under Fasting Conditions
TCTR20170622001Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sofosbuvir in hepatitis C virus infection (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on TCTR20170622001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170622001.